KHAZNEH, E., P. HRIBOVA, J. HOSEK, Pavel SUCHÝ, Peter KOLLÁR, G. PRAZANOVA, Jan MUSELÍK, Z. HANAKOVA, Jiří VÁCLAVÍK, M. MILEK, J. LEGATH a Karel ŠMEJKAL. The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease. Molecules. BASEL: Mayer und Muller, 2016, roč. 21, č. 4, 18 s. ISSN 1420-3049. Dostupné z: https://dx.doi.org/10.3390/molecules21040404.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease
Autoři KHAZNEH, E., P. HRIBOVA, J. HOSEK, Pavel SUCHÝ, Peter KOLLÁR, G. PRAZANOVA, Jan MUSELÍK, Z. HANAKOVA, Jiří VÁCLAVÍK, M. MILEK, J. LEGATH a Karel ŠMEJKAL.
Vydání Molecules, BASEL, Mayer und Muller, 2016, 1420-3049.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 2.861
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.3390/molecules21040404
UT WoS 000375155000017
Klíčová slova anglicky Achillea wilhelmsii; anti-hypercholesterolemic; cardiometabolic disease; docking; flavonoids; 3-hydroxy-3-methylglutaryl-CoA reductase; hypoglycemic; inflammation
Změnil Změnila: PharmDr. Jitka Michlíčková, učo 151288. Změněno: 24. 2. 2021 14:15.
Anotace
This study was done to identify the content compounds of Achillea wilhelmsii (A. wilhelmsii) and to evaluate its hypoglycemic and anti-hypercholesterolemic activity and effect on inflammatory mediators. The extracts and fractions of A. wilhelmsii were thoroughly analyzed using high performance liquid chromatography (HPLC), and the total content of phenols and flavonoids was determined. The hypoglycemic activity was evaluated in vivo using alloxan-induced diabetic mice. The effect upon inflammatory mediators was evaluated in vitro using the human monocytic leukemia cell line (THP-1). The anti-hypercholesterolemic activity was evaluated in vitro using the 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase assay kit. The water extract (WE)-treated group showed the highest reduction in the fasting blood glucose levels (FBGL). The chloroform fraction (CF) and ethyl acetate fraction (EAF) both showed a significant ability to reduce the secretion of tumor necrosis factor alpha (TNF-alpha). The EAF, however, also attenuated the levels of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). The CF showed the most significant 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibition activity. The five main compounds in the CF were isolated and identified. Out of the five compounds in the CF, 1 beta,10 beta-epoxydesacetoxymatricarin (CP1) and leucodin (CP2) showed the highest anti-hypercholesterolemic potential. A molecular docking study provided corresponding results.
VytisknoutZobrazeno: 23. 9. 2024 13:23